[1]Sheer CJ.Mammalian G1cyclins[J].Cell, 1993, 73 (6) :1059-1065.
|
[2]刘勇.肿瘤细胞增殖调控的研究进展[J].实用癌症杂志, 1977, 12 (2) :155-157.
|
[3]刘勇.生物芯片技术及其在肿瘤研究中的应用[J].江西医学检验, 2002, 20 (6) :376-378.
|
[4]Kononen J, Bubeneorf L, Kallioniemi A, et al.Tissue microarrays for high-throughputmoleu molecular profiling of tumor specimens[J].Nat Med, 1998, 4 (7) :844-847.
|
[5]刘勇, 路名芝, 文进.细胞周期调控基因p21WAF1/CIP1在膀胱移行细胞癌中的表达[J].中华病理学杂志, 2000, 29 (6) :443-444.
|
[6]刘勇, 路名芝, 文进.细胞周期调控因子p27、cyclin E和Ki-67在早期胃癌中的表达[J].中华普通外科杂志, 2002, 17 (6) :366.
|
[7]Kamb A, Gruis NA, Weaver FJ, et al.A cell cycle regulator po-tentially involved in genesis of many types[J].Science, 1994, 264 (5157) :436-440.
|
[8]刘勇, 路名芝, 李启明.肺癌中MTS1/p16和p53基因产物表达与细胞增殖的关系[J].临床与实验病理学杂志, 1998, 14 (2) :134-136.
|
[9]刘勇, 李启明, 王夷黎, 等.p16, p53蛋白和增殖细胞抗原在早期胃癌中的表达[J].中华实验外科杂志, 1999, 16 (6) :573.
|
[10]Masuda M, Hirakawa N, Nakasshima T, et al.cyclin D1overex-pression in primary hypoharyngeal carcinomas[J].Cancer, 1996, 78 (3) :390-395.
|
[11]杨海玉, 刘勇, 路名芝.肺癌中抑癌基因p21和癌基因cyclin D1的表达[J].中华结核与呼吸杂志, 2000, 23 (11) :703 (附插页) .
|
[12]徐晓军, 罗仑昆, 何振平, 等.细胞周期相关基因cyclin D1在胆管癌中的表达及其临床意义[J].中国普通外科杂志, 2004, 13 (2) :138-139.
|
[13]董俊峰, 吴小鹏.原发性肝细胞癌Survivin, cyclin D1的表达及其临床意义[J].中国普通外科杂志, 2007, 10 (2) :156-159.
|
[14]李宏涛, 袁晟, 李艳琴, 等.采用组织芯片技术检测大肠癌组织中p16和cyclin D1的表达[J].临床肿瘤学杂志, 2004, 9 (5) :456-458.
|
[15]李宏涛, 熊永萍, 徐明亮, 等.组织芯片技术应用于检测乳腺癌组织中p16和cyclin D1的表达[J].中国普通外科杂志, 2008, 17 (5) :494-496.
|
[16]袁松林, 汤辉焕.p16、cyclin D1在胆管癌中的表达及意义[J].医学临床研究, 2007, 24 (7) :1133-1135.
|
[1] | Hou YiHui, Liu TengFei, Zhao XiaoQing, Zhang LiaoYun. Effect of different direct-acting antivirals on the clinical outcome of genotype 1b chronic hepatitis C and compensated hepatitis C cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 84-87. doi: 10.3969/j.issn.1001-5256.2020.01.019 |
[2] | Zhang JieBing, Guo HongHua. Research advances in hepatitis B cirrhosis with renal injury and the application of antiviral drugs[J]. Journal of Clinical Hepatology, 2019, 35(1): 191-196. doi: 10.3969/j.issn.1001-5256.2019.01.042 |
[3] | Zhang Xi, Li YongGuo. Current status of the application of direct-acting antiviral agents in treatment of chronic hepatitis C and existing problems[J]. Journal of Clinical Hepatology, 2018, 34(4): 853-857. doi: 10.3969/j.issn.1001-5256.2018.04.034 |
[4] | Ren Shan, Chen XinYue. Current research on hepatitis C virus resistance to direct-acting antiviral agents[J]. Journal of Clinical Hepatology, 2015, 31(11): 1807-1812. doi: 10.3969/j.issn.1001-5256.2015.11.010 |
[5] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[6] | Zhang YanMei, Ding XiaoHui. Anti-viral therapy in adult patients with acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1327-1330+1344. |
[7] | Guo XinHui, Yan Yan, Li Zhuo, Yin JiMing. Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 65-67. |
[8] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[9] | Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290. |
[10] | Qin Hua, Wu XiaoQing. Distribution and clinical significance of HBV genotypes in Lanzhou district[J]. Journal of Clinical Hepatology, 2010, 26(3): 295-296. |
[11] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[12] | Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394. |
[13] | Chen Yan, Tian DeYing, Xia NingShao. Epidemiology and the genotypes of HEV isolated from patients with hepatitis E in Wuhan[J]. Journal of Clinical Hepatology, 2006, 22(1): 36-38. |
[14] | Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106. |
[15] | Liu ChengYong, Hou YuanPei, Qian XiuMei, Sun Qing, Song Li. Distribution of hepatitis B virus genotype in Xuzhou and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(3): 151-152. |
[16] | Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18. |
[18] | Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159. |
[19] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |
[20] | Yao Gang, Zhang Lian, Bao LiHua. HBV genotypes and efficacy of interferon-α on patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(5): 273-274. |